Earth Science Tech, Inc. has expanded its state licensure footprint to near-national coverage for its compounding pharmacies and telemedicine platforms, as reported in its February 2026 quarterly filing. This expansion underpins scalable patient acquisition and prescription fulfillment through vertically integrated subsidiaries combining asynchronous telemedicine consultations with proprietary sterile compounding pharmacies. The real estate asset management arm supports infrastructure needs and manages a disciplined share repurchase program backed by substantial insider ownership. Operating within a complex regulatory landscape and competitive environment, ETST leverages integration across clinical consultation, medication fulfillment, and consumer product innovation to differentiate itself. Key growth drivers include expanded pharmacy licensing, increased telehealth acceptance, scaling sterile compounding capacity, and diversification through proprietary consumer products.